401 Odcinki

  1. Episode 243: ASCO 2023 TALAPRO-2: Phase 3 Study of Talazoparib + Enzalutamide

    Opublikowany: 5.06.2023

  2. Episode 242: ASCO 2023 THOR study - erdafitinib vs chemo in bladder cancer

    Opublikowany: 5.06.2023

  3. Episode 241: Statistics for clinical trials

    Opublikowany: 1.06.2023

  4. Episode 240: Preview of GU Cancer at ASCO 2023

    Opublikowany: 30.05.2023

  5. Episode 239: The STAMPEDE trial

    Opublikowany: 22.05.2023

  6. Episode 238: Paper of the month: Biomarkers for neoadjuvant PD(L)1 therapy

    Opublikowany: 14.05.2023

  7. Episode 237: 2023 AUA Highlights

    Opublikowany: 9.05.2023

  8. Episode 236: ODAC for olaparib

    Opublikowany: 2.05.2023

  9. Episode 235: Danny Heng and the IMDC classification in renal cancer

    Opublikowany: 24.04.2023

  10. Episode 234: Amar Kishan, MD, on Neoadjuvant or Adjuvant Radiotherapy for Prostate Cancer

    Opublikowany: 19.04.2023

  11. Episode 233: Destaques da 14ª reunião internacional brasileira de câncer urológico

    Opublikowany: 15.04.2023

  12. Episode 232: Belzutifan in early and late renal cancer

    Opublikowany: 14.04.2023

  13. Episode 231: Ursula Vogl, MD in the Rising Star Series

    Opublikowany: 5.04.2023

  14. Episode 230: FGFR Inhibition in NMIBC With Sia Daneshmand

    Opublikowany: 28.03.2023

  15. Episode 229: Kala Sridhar, MD on PET in Early Bladder Cancer

    Opublikowany: 20.03.2023

  16. Episode 228: Karine Tawagi, MD in the Rising Star Series

    Opublikowany: 15.03.2023

  17. Episode 227: 2023 ASCO GU Bladder Highlights and Paper of the Month with Michiel Van der Heijden

    Opublikowany: 6.03.2023

  18. Episode 226: 2023 ASCO GU Prostate and RCC Highlights With Dan George

    Opublikowany: 27.02.2023

  19. Episode 225: ASCO GU 2023: Brian Shuch, MD discusses the ZIRCON Phase III Study of girentuximab PET/CT imaging in RCC

    Opublikowany: 20.02.2023

  20. Episode 224: ASCO GU 2023: discussing miR371 for Germ Cell Tumors with Christian Kollmannsberger

    Opublikowany: 20.02.2023

9 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site